Stay updated on Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Introduces Show glossary and Hide glossary options and adds labels such as 'Last Update Submitted that Met QC Criteria' with revision text. These changes are mainly UI and metadata tweaks and do not alter core study content.
    Difference
    0.2%
    Check dated 2026-01-23T05:41:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision label updated to v3.3.4, replacing the previous v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-16T04:31:54.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing participating sites by state (Alabama, Arkansas, California, Colorado, etc.) and updated the revision to v3.3.3. The previous standalone location blocks and the HHS Vulnerability Disclosure text were replaced.
    Difference
    2%
    Check dated 2025-12-24T23:13:05.000Z thumbnail image
  5. Check
    71 days ago
    Change Detected
    Summary
    The Publications section text now states that publications are automatically filled from PubMed, replacing the prior wording. The page revision has been updated to v3.3.2 (from v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-25T11:16:39.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page's government funding disclaimer was removed; this does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:10:58.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    No significant changes to core study content observed between the two screenshots; the title, conditions, eligibility criteria, interventions, outcomes, and location lists appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:10:50.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial page.